Production facility

BMC NANOLEK provides for the use of several technologies to ensure full-cycle production of drugs.
  • Production of solid dosage forms. Start of production - December 2014.
  • Biotechnological production (in syringes and vials). Start of full-cycle production – 4th quarter of 2016.
  • Production of cytostatic drugs in solid and injectable dosage forms.
  • Laboratories: chemical-analytical, microbiological, biochemical.

 

Capabilities of manufacturing site
  • Construction "from greenfield" (14 hectares, with an area of 29 000 sq. m.), GMP, ISO
  • Capability of implementing new global pharmaceutical technologies on a full cycle
  • Three separate sites for different types of pharmaceutical production
  • A full line of state-of-the-art laboratory equipment providing quality control of any complexity

 

Manufacturing facilities
  • Solid dosage forms - up to 4 billions of tablets per year
  • Filling into syringes – up to 42 millions of syringes per year
  • Filling into vials – up to 35 millions of vials per year
  • Lyophilic products in vials – up to 1.8 millions of vials per year